Optellum
optellum.com
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$14M
14 rounds on record
Latest round
Venture round
Aug 2026 · 2 mo ago
Team
34
UK accounts · Dec 2025 · -6% in a year
Grants
$677k
4 grants · CORDIS
Backers
1
IQ Capital
The money's age
Fresh money
2 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 3
Raised a round Venture round
Jun 3
Partnership Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients · optellum.com
Feb 2
Won a customer Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative · fiercebiotech.com
Jul 4, 2025
Raised a round Venture round
Mar 14, 2025
Raised a round Venture round
Jun 28, 2024
Raised a round Venture round
Sep 30, 2022
Raised a round Venture round
Sep 26, 2022
Raised a round Series A $14M · Nasdaq
Oct 8, 2021
Raised a round Venture round
Mar 23, 2021
Certified Optellum Receives FDA Clearance for the World's First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis · businesswire.com
Dec 8, 2020
Raised a round Venture round
Jul 1, 2020
Won a grant $597k · CORDIS
Jul 4, 2019
Raised a round Venture round
Jan 1, 2019
Won a grant CORDIS
Jun 30, 2017
Raised a round Venture round
Dec 1, 2016
Won a grant $27k · CORDIS
Apr 1, 2016
Won a grant $54k · CORDIS
2016
Founded
Oct 28, 2015
Incorporated OPTELLUM LTD · Companies House
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jul 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jun 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Sep 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Series A | Sep 2022 | $14M | Intuitive Ventures, Black Opal Ventures | Nasdaq |
| Venture round | Oct 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2020 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jul 2020 | $597k | — | CORDIS |
| Venture round | Jul 2019 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jan 2019 | — | — | CORDIS |
| Venture round | Jun 2017 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Dec 2016 | $27k | — | CORDIS |
| Grant | Apr 2016 | $54k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | OPTELLUM LTD | Companies House |
| Registered | 28 Oct 2015 |
Backed byfrom the funds' portfolios and accelerator catalogs
IQ Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Noah Medical is a medical robotics company that builds the Galaxy System, a robotic bronchoscopy platform for lung nodule biopsy. Its…
Agamon makes it easy to bring more patients back for radiology follow-ups. Manage Lung Cancer Screening programs, urgent and findings…
Company Focus Our mission is to pioneer early lung cancer detection and save lives. Lung cancer is the second most common cancer worldwide…
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
Skip to the content About Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do…
See-Mode Technologies builds AI that automates ultrasound analysis and reporting for thyroid and vascular scans. Its software is cleared…
Overview
Optellum is an Oxford company founded in 2016 that helps clinicians decide how to manage lung nodules found on scans. Its Virtual Nodule Clinic scores the likelihood of malignancy so patients are neither over-investigated nor diagnosed too late. The software is cleared in the United States and used in lung cancer pathways.
News
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated Lung Cancer Diagnosis
OXFORD, United Kingdom and HOUSTON, June 15, 2026 - Optellum, a leader in AI-enabled lung cancer diagnostics, today announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive
Read more
Report
Tanner Health and Healthliant Ventures Partner with Optellum to Bring AI for Lung Health to the Region
Carrollton, Georgia, June 10, 2026 - Tanner Health and Healthliant Ventures announce the launch of Optellum's Virtual Nodule Clinic (VNC), an artificial intelligence (AI) platform designed to assist care teams in identifying, risk assessing and managing p
Read more
Report
Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing
OXFORD, United Kingdom and HOUSTON, United States, June 4, 2026 - Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores
Read more
Report
Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing
/PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3...
Read more
Report
Massive Bio and Optellum partner on early NSCLC detection and trials
The collaboration enables clinicians to receive timely information about relevant clinical trials for patients flagged as higher risk.
Read more
Report
Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing
Read more
Report
Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients
BOCA RATON, Fla., June 03, 2026--Massive Bio, a global leader in AI-driven precision oncology and clinical trial matching operating across 17+ countries, and Optellum, the leader in AI-enabled lung cancer diagnosis and the developer of the world's first F
Read more
Report
Massive Bio and Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage Non-Small Cell Lung Cancer Patients
Boca Raton, FL - Massive Bio, a global leader in AI-driven precision oncology and clinical trial matching operating across 17+ countries, and Optellum, the leader in AI-enabled lung cancer diagnosis and the developer of the world's first FDA-cleared clini
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Oxford
United Kingdom
HQ
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
50-200 est. staff
5 Kings Meadow, Osney Mead, Ferry Hinksey Road, Oxford,, Oxfordshire, England, OX2 0DP, United Kingdom
Financials
Total raised
$14.7M
Latest round
Venture - Series Unknown
Funding rounds
14
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | — | Details |
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Series A | 2022 | $14M | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Grant | 2020 | $597k | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Grant | 2019 | — | Details |
| Venture - Series Unknown | 2017 | — | Details |
| Grant | 2016 | $27k | Details |
| Grant | 2016 | $54k | Details |